Herb & supplement monograph

Iron Drug Interactions, Uses, Effectiveness, Safety & More

Check Iron against your medication

Add one medication
Iron
+
Start typing any prescription or over-the-counter drug name.
Reviewed by licensed pharmacists Sourced from Natural Medicines

Iron Drug Interactions: The Bottom Line

From the HelloPharmacist Editorial Team · Updated July 2026

Based on the available evidence, the overall risk of a clinically significant Iron drug interaction is moderate for most people, because iron can bind to many medicines in the gut and lower the amount the body absorbs. None of the listed interactions are rated major, but nearly all are moderate, and several are supported by human studies.

Interactions deserving the most attention

The best-documented concerns involve medicines where a drop in absorption can really matter. Human evidence shows iron can reduce absorption of levothyroxine, weakening thyroid control, and cut absorption of levodopa by around half, which could affect Parkinson's symptoms. Iron also lowers levels of HIV medicines such as dolutegravir, and can sharply reduce absorption of tetracycline and quinolone antibiotics, methyldopa (a blood pressure medicine), penicillamine, and bisphosphonates. In nearly all of these cases, the issue is timing rather than a dangerous reaction, and spacing doses apart is how it is typically managed.

What the rest of the list means

Although the list of interacting medicines is long, most share one simple mechanism: iron sticks to other drugs in the digestive tract so less gets absorbed. That does not make every combination harmful, and some predicted effects, such as with mycophenolate, have not shown meaningful changes in people.

Check your medications against Iron

Based on HelloPharmacist’s Iron interaction data and reviewed under our editorial standards.

Interaction report

Drugs that interact with Iron

80 medications have a known interaction with Iron, graded by severity. Select any drug for the full evidence-based detail.

2,830 drugs
AlendronateBinosto, Fosamax› Alendronate Sodium› Alendronate Sodium, CholecalciferolFosamax Plus D› Amphotericin, TetracyclineMysteclin-F› Benserazide, LevodopaMadopar, Prolopa› Bictegravir, Emtricitabine, Tenofovir AlafenamideBiktarvy› Bismuth Subsalicylate, Metronidazole, TetracyclineHelidac› Carbidopa, LevodopaDhivy, Rytary, Sinemet, Sinemet CR› Carbidopa, Levodopa, EntacaponeStalevo› Chlorothiazide, MethyldopaAldochlor, Aldoclor 150, Aldoclor 250› ChlortetracyclineAureomycin› CinoxacinCinobac› CiprofloxacinCiloxan, Cipro, Cipro IV, Cipro XR, Ciprobay, Otiprio› ClinafloxacinClinafloxacin› Cobicistat, Elvitegravir, Emtricitabine, Tenofovir Alafenamide FumarateGenvoya› Darunavir, Cobicistat, Emtricitabine, Tenofovir AlafenamideSymtuza› DemeclocyclineDeclomycin› DenosumabProlia, XGEVA› DolutegravirTivicay› Dolutegravir, Emtricitabine, Tenofovir AlafenamideDolutegravir, Emtricitabine, Tenofovir Alafenamide› Dolutegravir, RilpivirineJuluca› DoripenemDoribax› DoxycyclineDoryx, Doxy, Doxy-D, Doxycin, Doxycycline Injection, Doxylin +6 more› Doxycycline HyclateActiclate, Acticlate Cap, Lymepak› Doxycycline MonohydrateErfacea› DoxycylineDoxychel› Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil FumarateStribild› EmtricitabineEmtriva› Emtricitabine, Rilpivirine, TenofovirComplera› Emtricitabine, Rilpivirine, Tenofovir AlafenamideOdefsey›
Read The List Like a Pharmacist

What Severity, Likelihood & Evidence Mean

Severity — How Serious It Can Be

  • Major. Clinically significant; generally best avoided, or used only under direct professional supervision.
  • Moderate. May need monitoring, a dose adjustment, or separating the times you take each one.
  • Minor. Generally not clinically significant, but still worth noting and mentioning to your pharmacist.
  • No known interaction. Checked against our sources with nothing documented — not the same as proven safety.

Likelihood — How Well It’s Documented

  • Likely. Well-controlled human studies have demonstrated the likely existence of this interaction
  • Probable. Interaction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
  • Possible. Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists
  • Unlikely. Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans.

Where This Data Comes From

  • Interaction records are evidence-graded and sourced from the Natural Medicines database (TRC Healthcare), the same reference used by pharmacists and hospitals.
  • Each drug listed above links to the full report for that exact Iron combination — clinical detail, likelihood, evidence level, and citations.
  • Content is reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
The big picture

The kinds of drugs Iron affects

Every type of medication (drug category) Iron is known to interact with. Open any category for the detail — or search your exact drug in the checker above.

All 13 drug categories Iron interacts with
Bictegravir/emtricitabine/tenofovir Alafenamide (biktarvy)BisphosphonatesDenosumab (prolia, Others)Dolutegravir (tivicay)Integrase InhibitorsLevodopaLevothyroxine (synthroid, Others)Methyldopa (aldomet)Mycophenolate Mofetil (cellcept)Penicillamine (cuprimine, Depen)Quinolone AntibioticsTetracycline AntibioticsChloramphenicol
Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy)

Iron might decrease levels of bictegravir/emtricitabine/tenofovir alafenamide by reducing its absorption when taken in a fasting state.
Advise patients that bictegravir/emtricitabine/tenofovir alafenamide and iron can be taken together if taken with food. However, if taken on an empty stomach, bictegravir/emtricitabine/tenofovir alafenamide should not be taken with, or 2 hours after, iron containing products.

Likelihood Probable Evidence D
Bisphosphonates

Iron reduces the absorption of bisphosphonates.
Advise patients that doses of bisphosphonates should be separated by at least two hours from doses of all other medications, including supplements such as iron. Divalent cations, including iron, can decrease absorption of bisphosphonates by forming insoluble complexes in the gastrointestinal tract.

Likelihood Probable Evidence D
Denosumab (Prolia, Others)

Administration of intravenous iron within one month of denosumab administration might increase the risk of severe hypophosphatemia and hypocalcemia.
A case of severe hypocalcemia (albumin corrected calcium 6.88 mg/dL, ionized calcium 3.68 mg/dL) and hypophosphatemia (<0.5 mg/dL) with respiratory acidosis, QT interval prolongation, and nonsustained ventricular tachycardia was reported in a 76-year-old male who had received an iron polymaltose infusion within 2 weeks of a subcutaneous injection of denosumab. Serum parathyroid hormone was also elevated (348 pg/mL). Subsequent iron infusions with iron polymaltose and ferric carboxymaltose were followed by transient hypophosphatemia, but without hypocalcemia. Additionally, a literature review describes 6 additional cases of hypophosphatemia and hypocalcemia in patients 52-92 years of age who had been administered intravenous iron as either ferric carboxymaltose or iron polymaltose and subcutaneous denosumab within 1-4 weeks of each other.

Likelihood Possible Evidence D
Dolutegravir (Tivicay)

Iron might decrease dolutegravir levels by reducing its absorption.
Advise patients to take dolutegravir at least 2 hours before or 6 hours after taking iron. Pharmacokinetic research shows that iron can decrease the absorption of dolutegravir from the gastrointestinal tract through chelation. When taken under fasting conditions, a single dose of ferrous fumarate 324 mg orally along with dolutegravir 50 mg reduces overall exposure to dolutegravir by 54%.

Likelihood Probable Evidence B
Integrase Inhibitors

Theoretically, taking iron along with integrase inhibitors might decrease the levels and clinical effects of these drugs.
Iron is a divalent cation. There is concern that iron may decrease the absorption of integrase inhibitors from the gastrointestinal tract through chelation. One pharmacokinetic study shows that iron can decrease blood levels of the specific integrase inhibitor dolutegravir through chelation. Also, other pharmacokinetic research shows that other divalent cations such as calcium can decrease the absorption and levels of some integrase inhibitors through chelation.

Likelihood Possible Evidence D
Levodopa

Iron might decrease levodopa levels by reducing its absorption.
Advise patients to separate doses of levodopa and iron as much as possible. There is some evidence in healthy people that iron forms chelates with levodopa, reducing the amount of levodopa absorbed by around 50%. The clinical significance of this hasn't been determined.

Likelihood Probable Evidence B
Levothyroxine (Synthroid, Others)

Iron might decrease levothyroxine levels by reducing its absorption.
Advise patients to separate levothyroxine and iron doses by at least 2 hours. Iron can decrease the absorption and efficacy of levothyroxine by forming insoluble complexes in the gastrointestinal tract.

Likelihood Probable Evidence B
Methyldopa (Aldomet)

Iron might decrease methyldopa levels by reducing its absorption.
Advise patients to separate methyldopa and iron doses by at least 2 hours. Iron can decrease the absorption of methyldopa from the gastrointestinal tract through chelation, resulting in increases in blood pressure.

Likelihood Probable Evidence B
Mycophenolate Mofetil (Cellcept)

Theoretically, iron might decrease mycophenolate mofetil levels by reducing its absorption.
Advise patients to take iron 4-6 hours before, or 2 hours after, mycophenolate mofetil. It has been suggested that a decrease of absorption is possible, probably by forming nonabsorbable chelates. However, mycophenolate pharmacokinetics are not affected by iron supplementation in available clinical research.

Likelihood Unlikely Evidence D
Penicillamine (Cuprimine, Depen)

Iron might decrease penicillamine levels by reducing its absorption.
Advise patients to separate penicillamine and iron doses by at least 2 hours. Oral iron supplements can reduce absorption of penicillamine by 30% to 70%, probably due to chelate formation. In people with Wilson's disease, this interaction has led to reduced efficacy of penicillamine.

Likelihood Probable Evidence D
Quinolone Antibiotics

Iron might decrease levels of quinolone antibiotics by reducing their absorption.
Advise patients to separate quinolone antibiotics and iron doses by at least 2 hours. Iron decreases the absorption of quinolones due to formation of insoluble complexes in the gastrointestinal tract.

Likelihood Probable Evidence D
Tetracycline Antibiotics

Iron might decrease levels of tetracycline antibiotics by reducing their absorption.
Advise patients to take iron at least 2 hours before or 4 hours after tetracycline antibiotics. Concomitant use can decrease absorption of tetracycline antibiotics from the gastrointestinal tract by 50% to 90%.

Likelihood Probable Evidence D
Chloramphenicol

Theoretically, taking chloramphenicol with iron might reduce the response to iron therapy in iron deficiency anemia.
Chloramphenicol interferes with erythrocyte maturation. However, since chloramphenicol isn't usually taken for prolonged periods, this isn't likely to be clinically significant.

Likelihood Unlikely Evidence D
Monograph

Iron: Uses, Safety & Side Effects

The bottom line

Iron is an essential mineral your body needs to make hemoglobin and carry oxygen in the blood. Supplements are mainly useful for treating or preventing iron deficiency and iron-deficiency anemia, ideally after a blood test confirms you are low. Because too much iron can be harmful, take it only when needed and under the guidance of a pharmacist or doctor.

Part used
Mineral (essential trace element)
Common forms
Tablets, capsules, liquid/drops, gummies, chewables, and intravenous (IV) preparations
People commonly use it for
  • Iron-deficiency anemia
  • Low iron stores during pregnancy
  • Fatigue from iron deficiency
  • Heavy menstrual blood loss
  • Restless legs syndrome (with low iron)

Popular and traditional uses — not proof it works. See “Uses & effectiveness” below for the evidence.

Safety at a glance
OverallUse caution

Generally safe at recommended doses, but excess iron can be toxic and supplements should be used when there is a real need.

PregnancyLikely Safe

When used orally and appropriately. Iron is safe during pregnancy and breast-feeding in patients with adequate iron stores when used in doses below th...

Read the full pregnancy detail
BreastfeedingLikely Safe

When used orally and appropriately. Iron is safe during pregnancy and breast-feeding in patients with adequate iron stores when used in doses below th...

Read the full breastfeeding detail

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center). Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Jump to a section

Overview

Iron is an essential mineral that your body needs to survive. It is a key part of hemoglobin, the protein in red blood cells that carries oxygen from your lungs to the rest of your body. Iron is also used to make myoglobin (a protein in muscle) and is needed for many other processes, including energy production.

You normally get iron from foods such as red meat, poultry, fish, beans, lentils, tofu, and iron-fortified cereals. When diet alone is not enough, or when blood loss or higher needs leave you short, iron supplements may be used to restore healthy levels.

Supplements come in several forms, such as ferrous sulfate, ferrous gluconate, and ferrous fumarate, as well as liquids, gummies, and IV products used in clinics for more serious deficiency.

How it works

Iron is a building block of hemoglobin and myoglobin, the proteins that carry and store oxygen. Without enough iron, your body cannot make enough healthy red blood cells, which leads to anemia and symptoms like fatigue and shortness of breath.

When you take an iron supplement, the iron is absorbed mostly in the small intestine and used by the bone marrow to make new red blood cells. Vitamin C can help your body absorb iron better, while certain foods and drinks (like tea, coffee, dairy, and high-calcium meals) can reduce absorption.

Your body has no easy way to get rid of extra iron, so it tightly controls how much it absorbs. This is why taking more iron than you need can lead to a harmful buildup over time.

Effectiveness

Does Iron work?

Evidence overview · 19 uses evaluated
3 Effective 4 Possibly effective 2 Leans ineffective 10 Insufficient evidence
How to read these evidence grades

Natural Medicines’ 7-point scale. We show each rating’s label word-for-word.

1EffectiveStrong, consistent evidence it works.
2Likely EffectiveGood evidence, though not yet conclusive.
3Possibly EffectiveSome evidence suggests a benefit.
4Possibly IneffectiveSome evidence it may not help.
5Likely IneffectiveFairly strong evidence it doesn’t help.
6IneffectiveStrong evidence it doesn’t work.
7Insufficient Reliable Evidence to RateToo little research to say either way.
Effective Anemia of chronic disease
Rating & evidence shown verbatim from Natural Medicines

Oral and intravenous (IV) iron in combination with erythropoiesis-stimulating agents (ESAs) are effective for treating anemia of chronic disease.

Effective Iron deficiency anemia
Rating & evidence shown verbatim from Natural Medicines

Oral and intravenous (IV) iron are effective for treating or preventing iron deficiency anemia. The benefits of iron supplementation in people with iron deficiency without anemia are unclear.

Effective Pregnancy-related iron deficiency
Rating & evidence shown verbatim from Natural Medicines

Oral and intravenous (IV) iron are effective for managing pregnancy-related iron deficiency.

Possibly Effective Breath-holding attacks
Rating & evidence shown verbatim from Natural Medicines

Oral iron seems to be effective for reducing the frequency of breath-holding attacks in children with iron deficiency.

Possibly Effective Cognitive function
Rating & evidence shown verbatim from Natural Medicines

Oral iron seems to be effective for improving cognitive function in children and adolescents with iron deficiency.

Possibly Effective Heart failure
Rating & evidence shown verbatim from Natural Medicines

Intravenous (IV) iron seems to be effective for improving certain outcomes in patients with heart failure and iron deficiency. It is unclear if oral iron is effective.

Possibly Effective Restless legs syndrome (RLS)
Rating & evidence shown verbatim from Natural Medicines

Oral and intravenous (IV) iron seem to be beneficial for RLS. The American Academy of Neurology recommends a combination of oral ferrous sulfate and vitamin C or IV ferric carboxymaltose for patients with RLS.

Possibly Ineffective Athletic performance
Rating & evidence shown verbatim from Natural Medicines

Oral iron does not seem to improve athletic performance.

Possibly Ineffective Preterm labor
Rating & evidence shown verbatim from Natural Medicines

Oral iron does not seem to prevent preterm labor and may actually increase the risk in malaria-endemic regions.

Also studied for 10 conditions — evidence insufficient to rate
Insufficient Reliable Evidence To Rate ACE inhibitor-induced cough
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral iron is beneficial in patients with this condition.

Insufficient Reliable Evidence To Rate Androgenic alopecia
Rating & evidence shown verbatim from Natural Medicines

Oral iron has only been evaluated in combination with other ingredients, its effect when used alone is unclear.

Insufficient Reliable Evidence To Rate Attention deficit-hyperactivity disorder (ADHD)
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral iron is beneficial in children with ADHD.

Insufficient Reliable Evidence To Rate Child development
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral iron is beneficial for improving development in non-anemic children.

Insufficient Reliable Evidence To Rate Esophageal cancer
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral iron is beneficial for esophageal cancer prevention.

Insufficient Reliable Evidence To Rate Fatigue
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral iron is beneficial in patients with fatigue due to iron deficiency without anemia.

Insufficient Reliable Evidence To Rate Inflammatory bowel disease (IBD)
Rating & evidence shown verbatim from Natural Medicines

In patients with active IBD, intravenous iron may be more beneficial than oral iron due to impaired absorption. However, it may also increase the risk of infection in these patients.

Insufficient Reliable Evidence To Rate Postoperative recovery
Rating & evidence shown verbatim from Natural Medicines

It is unclear if intravenous (IV) iron is beneficial for recovery following cardiac surgery.

Insufficient Reliable Evidence To Rate Postpartum depression
Rating & evidence shown verbatim from Natural Medicines

Although there has been interest in using iron for postpartum depression, there is insufficient reliable information about the clinical effects of iron for this condition.

Insufficient Reliable Evidence To Rate Prematurity
Rating & evidence shown verbatim from Natural Medicines

Enteral iron seems to be beneficial for some measures of development in preterm infants.

Source & disclaimer. Effectiveness ratings and evidence summaries are provided by Natural Medicines (Therapeutic Research Center) and shown as licensed. Where Natural Medicines hasn’t rated a use, HelloPharmacist’s pharmacists may add their own reviewed rating and evidence (each such entry is labeled). This is educational information, not medical advice — talk with your pharmacist or doctor before starting, stopping, or changing a supplement.

Safety & precautions

Iron is safe and important when used to correct a real deficiency, but more is not better. Taking iron when you do not need it can cause unwanted buildup. People with conditions that cause iron overload, such as hemochromatosis, should not take iron unless a doctor directs it.

Pregnancy: Iron needs rise during pregnancy, and providers often recommend it as part of prenatal care. Still, the right dose should be guided by your doctor or midwife, since both too little and too much can be a problem.

Breastfeeding: Iron at appropriate doses is generally considered acceptable while nursing, but check with your provider before starting a supplement.

Children: Iron poisoning is one of the most common causes of serious poisoning in young children. Keep all iron-containing products tightly closed and out of reach, and seek emergency help immediately if a child swallows iron pills.

Side effects

The most common side effects are stomach-related, including nausea, stomach cramps, constipation, diarrhea, and a metallic taste. Iron can also turn the stool dark or black, which is harmless but can be mistaken for bleeding.

Taking iron with food can ease stomach upset, though it may slightly lower absorption. Different forms or lower doses (sometimes taken every other day) may be better tolerated.

Serious but rare: Taking very large amounts of iron, especially accidental overdose in children, can cause severe and even life-threatening poisoning. Signs may include severe vomiting, bloody diarrhea, belly pain, and shock. This is a medical emergency.

Iron: Reported Adverse Effects

Documented safety reports on Iron from the evidence-graded Natural Medicines (TRC Healthcare) database, shown word-for-word from the licensed record.

Orally or intravenously, iron is generally well tolerated when used appropriately.

Most Common Adverse Effects:

Orally: Abdominal pain, constipation, diarrhea, gastrointestinal irritation, nausea, and vomiting.

Serious Adverse Effects (Rare):

Orally: Case reports have raised concerns about oral or gastric ulcerations.

Intravenously: Case reports have raised concerns about hypophosphatemia and osteomalacia.

Reports by condition
Alcohol-related liver disease Cardiovascular

There is debate regarding the association between coronary heart disease (CHD) or myocardial infarction (MI) and high iron intake or high body iron stores. Some observational studies have reported that high body iron stores are associated with increased risk of MI and CHD. Some observational studies reported that only high heme iron intake from dietary sources such as red meat are associated with increased risk of MI and CHD. However, the majority of research has found no association between serum iron levels and cardiovascular disease .

There is one case of Kounis syndrome, also referred to as allergic angina or allergic myocardial infarction, in a 39-year-old female patient without previous coronary artery disease given intravenous ferric carboxymaltose. The patient experienced anaphylactic symptoms, including headache, abdominal pain, and breathing difficulties, 3 minutes after starting the infusion. She was further diagnosed with non-ST-elevation myocardial infarction.

There is also a case of a 56-year-old female, negative for HFE mutation homozygosity, diagnosed with acquired iron overload cardiomyopathy after starting ferrous sulfate 325 mg twice daily 3 years prior for iron deficiency secondary to alcoholic cirrhosis with esophageal varices and encephalopathy. The patient had no follow-up care over the 3 years and denied any blood transfusions over that time.

  1. Klipstein-Grobusch K, Grobbee DE, den Breeijen JH, et al. Dietary iron and risk of myocardial infarction in the Rotterdam Study. Am J Epidemiol 1999;149:421-8.
  2. Schumann K, Borch-Iohnsen B, Hentze MW, Marx JJ. Tolerable upper intakes for dietary iron set by the US Food and Nutrition Board (commentary). Am J Clin Nutr 2002;76:499-500.
  3. Tuomainen TP, Punnonen K, Nyyssonen K, Salonen JT. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 1998;97:1461-6..
  4. Salonen JT, Nyyssonen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 1992;86:803-11..
  5. Kiechl S, Willeit J, Egger G, et al. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997;96:3300-07.
  6. Jara Vidal M, López García MC, Quílez Toboso RP. Kounis syndrome after intravenous iron administration. Med Clin (Barc) 2023.
  7. Yerigeri K. Hemochromatosis in an Adult Female With Previous Iron Deficiency Anemia on Iron Supplementation. Cureus 2023;15(12):e50166.
Alcohol-related liver disease Hematologic

Orally, iron supplements have been associated with hemochromatosis. In one case report, a 56-year-old female, negative for HFE mutation homozygosity, was diagnosed with acquired hemochromatosis after starting ferrous sulfate 325 mg twice daily 3 years prior, without follow-up care, for a previous iron deficiency secondary to alcoholic cirrhosis with esophageal varices and encephalopathy.

  1. Yerigeri K. Hemochromatosis in an Adult Female With Previous Iron Deficiency Anemia on Iron Supplementation. Cureus 2023;15(12):e50166.
Alzheimer disease Gastrointestinal

Orally, iron can cause dry mouth, gastrointestinal irritation, heartburn, abdominal pain, constipation, diarrhea, nausea, or vomiting. These adverse effects are uncommon at doses below the tolerable upper intake level (UL) of 45 mg per day of elemental iron in adults with normal iron stores. Higher doses can be taken safely in adults with iron deficiency, but gastrointestinal side effects may occur. Taking iron supplements with food seems to reduce gastrointestinal side effects. However, food can also significantly reduce iron absorption. Iron should be taken on an empty stomach, unless it cannot be tolerated.

There are several formulations of iron products such as ferrous sulfate, ferrous gluconate, ferrous fumarate, and others. Manufacturers of some formulations, such as polysaccharide-iron complex products (Niferex-150, etc), claim to be better tolerated than other formulations; however, there is no reliable evidence to support this claim. Gastrointestinal tolerability relates mostly to the elemental iron dose rather than the formulation.

Enteric-coated or controlled-release iron formulations might reduce nausea for some patients, however, these products also have lower absorption rates.

Liquid oral preparations can blacken and stain teeth.

Iron can also cause oral ulcerations and ulcerations of the gastric mucosa. In one case report, an 87-year-old female with Alzheimer disease experienced a mucosal ulceration, possibly due to holding a crushed ferrous sulfate 80 mg tablet in the mouth for too long prior to swallowing. The ulceration was resolved after discontinuing iron supplementation. In another case report, a 76-year old male suffered gastric mucosal injury after taking a ferrous sulfate tablet daily for 4 years. In a third case report, a 14-year-old female developed gastritis involving symptoms of upper digestive hemorrhage, nausea, melena, and stomach pain. The hemorrhage was attributed to supplementation with ferrous sulfate 2 hours after meals for the prior 2 weeks. In one case report, a 43-year old female developed atrophic gastritis with non-bleeding ulcerations five days after starting oral ferrous sulfate 325 mg twice daily.

Intravenously, iron can cause gastrointestinal symptoms such as nausea and diarrhea.

  1. Low MS, Speedy J, Styles CE, De-Regil LM, Pasricha SR. Daily iron supplementation for improving anaemia, iron status and health in menstruating women. Cochrane Database Syst Rev. 2016;4:CD009747.
  2. Kaundal R, Bhatia P, Jain A, et al. Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia. Ann Hematol 2020;99(1):57-63.
  3. Li N, Zhao G, Wu W, et al. The efficacy and safety of vitamin C for iron supplementation in adult patients with iron deficiency anemia: A randomized clinical trial. JAMA Netw Open. 2020;3(11):e2023644.<br>
  4. Houston BL, Hurrie D, Graham J, et al. Efficacy of iron supplementation on fatigue and physical capacity in non-anaemic iron-deficient adults: a systematic review of randomised controlled trials. BMJ Open. 2018;8(4):e019240.
  5. Koch RM, Tchernodrinski S, Principe DR. Case report: Rapid onset, ischemic-type gastritis after initiating oral iron supplementation. Front Med (Lausanne) 2022;9:1010897.
  6. Rogozinska E, Daru J, Nicolaides M, et al. Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis. Lancet Haematol 2021;8(7):e503-e512.
  7. Gamad N, Saha PK, Sharma P, Suri V, Chakrabarti A, Saha L. A randomized controlled trial comparing the efficacy, tolerability, and cost of oral iron preparations in iron-deficiency anemia in pregnancy. J Obstet Gynaecol Res 2021;47(11):3828-3841.
  8. El-Hawy MA, Abd Al-Salam SA, Bahbah WA. Comparing oral iron bisglycinate chelate, lactoferrin, lactoferrin with iron and iron polymaltose complex in the treatment of children with iron deficiency anemia. Clin Nutr ESPEN 2021;46:367-371.
  9. Adams A, Scheckel B, Habsaoui A, et al. Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis. Cochrane Database Syst Rev 2
  10. Short V, Allen R, Earley CJ, et al. A randomized double-blind pilot study to evaluate the efficacy, safety, and tolerability of intravenous iron versus oral iron for the treatment of restless legs syndrome in patients with iron deficiency anemia. Am J Hem
  11. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002.
  12. Bruner AB, Joffe A, Duggan AK, et al. Randomized study of cognitive effects of iron supplementation in non- anaemic iron-deficient adolescent girls. Lancet 1996;348:992-6.
  13. Toblli J. E., Brignoli, R. Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis. Arzneimittelforschung 2007;57(6A):431-438.
  14. Köpcke W., Sauerland M. C. Meta-analysis of efficacy and tolerability data on iron proteinsuccinylate in patients with iron deficiency anemia of different severity. Arzneimittelforschung 1995;45(11):1211-1216.
  15. Macedo, A. and Cardoso, S. [Routine iron supplementation in pregnancy]. Acta Med Port. 2010;23(5):785-792.
  16. Comparison of oral iron supplements. Pharmacist's Letter / Prescriber's Letter 2008;24(8):240811.
  17. Zhang, X., Ouyang, J., Wieczorek, R., and DeSoto, F. Iron medication-induced gastric mucosal injury. Pathol.Res Pract 2009;205(8):579-581.
  18. Liabeuf S, Gras V, Moragny J, et al. Ulceration of the oral mucosa following direct contact with ferrous sulfate in elderly patients: a case report and a review of the French National Pharmacovigilance Database. Clin Interv Aging. 2014 Apr 25;9:737-40.
  19. Melit LE, Marginean CO, Mocanu S, Marginean MO. A rare case of iron-pill induced gastritis in a female teenager: A case report and a review of the literature. Medicine (Baltimore). 2017;96(30):e7550.
Anemia Musculoskeletal

Intravenous (IV) iron may trigger hypophosphatemia in some patients, and cases of osteomalacia related to hypophosphatemia subsequent to parenteral iron administration have been rarely reported . In one case, a 70-year-old male with a genetic hemorrhagic disorder infused with ferric carboxymaltose developed lower limb pain with hypophosphatemia and diffuse bone demineralization in the feet. In a second case, a 61-year-old male developed femoral neck insufficiency fractures following repeated ferric carboxymaltose transfusions for anemia related to vascular malformation in the bowel.

  1. Samões B, Silva B, Martins A, et al. Hypophosphatemic osteomalacia induced by intravenous iron therapy: a case report. Joint Bone Spine 2023;90(5):105586.
  2. Ye S, Grill V, Luo J, Nguyen HH. Concurrent Denosumab and Parenteral Iron Therapy Precipitating Severe Hypocalcemia and Hypophosphatemia. JCEM Case Rep 2024;2(2):luae005.
  3. Kancherla K, Constantin H, Kanawati A, Graham E. Iron-induced Hypophosphatemic Osteomalacia-An Atypical Case of Bilateral Femoral Stress Fractures. J Am Acad Orthop Surg Glob Res Rev 2023;7(5):e22.
Anemia Immunologic

Although there is some clinical research associating iron supplementation with an increased rate of malaria infection, the strongest evidence to date does not support this association, at least for areas where antimalarial treatment is available. In an analysis of 14 trials, iron supplementation was not associated with an increased risk of malaria. In a sub-analysis of 7 preliminary clinical studies, the effect of iron supplementation was dependent upon the access to services for antimalarial treatment. In areas where anemia is common and services are available, iron supplementation is associated with a 9% reduced risk of clinical malaria. In an area where services are unavailable, iron supplementation was associated with a 16% increased risk in malaria incidence. The difference in these findings is likely associated with the use of malaria prevention methods.

A meta-analysis of clinical studies of all patient populations shows that administering intravenous (IV) iron, usually iron sucrose and ferric carboxymaltose, increases the risk of infection by 16% when compared with oral iron or no iron. However, sub-analyses suggest this increased risk is limited to patients with inflammatory bowel disease (IBD). Additionally, a meta-analysis in adults with cancer-associated anemia shows that IV iron does not increase the risk of infection when compared with oral iron or no iron therapy.

Intravenously, iron has rarely resulted in allergic reactions, including anaphylactoid reactions. There is one case of Kounis syndrome, also referred to as allergic angina or allergic myocardial infarction, in a 39-year-old female patient without previous coronary artery disease given IV ferric carboxymaltose. The patient experienced anaphylactic symptoms, including headache, abdominal pain, and breathing difficulties, 3 minutes after starting the infusion. She was further diagnosed with non-ST-elevation myocardial infarction.

  1. van den, Hombergh J., Dalderop, E., and Smit, Y. Does iron therapy benefit children with severe malaria-associated anaemia? A clinical trial with 12 weeks supplementation of oral iron in young children from the Turiani Division, Tanzania. J.Trop.Pediatr.
  2. Esan MO, Boele van Hensbroek M, Nkhoma E, et al. Iron supplementation in HIV infected Malawian children with anemia: a double-blind, randomized, controlled trial. Clin Inf Dis 2013;57(11):1626-34.doi:10.1093/cid/cit528.
  3. Zlotkin S, Newton S, Aimone AM, et al. Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial. JAMA 2013;310(9):938-47.
  4. Neuberger A, Okebe J, Yahav D, Paul M. Oral iron supplements for children in malaria-endemic areas. Cochrane Database Syst Rev. 2016;2:CD006589.
  5. Shah AA, Donovan K, Seeley C, et al. Risk of infection associated with administration of intravenous iron: A systematic review and meta-analysis. JAMA Netw Open 2021;4(11):e2133935.
  6. Meyers M, Salmon M, Libert I, Klá&scaron;terský J. A meta-analysis on the risk of infection associated with intravenous iron therapy in cancer-associated anaemia: a double-edged sword?. Curr Opin Oncol 2024;36(4):223-232.
  7. Rogozinska E, Daru J, Nicolaides M, et al. Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis. Lancet Haematol 2021;8(7):e503-e512.
  8. Adams A, Scheckel B, Habsaoui A, et al. Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis. Cochrane Database Syst Rev 2
  9. Varandas C, Vieira J, Correia CJ, et al. Hypersensitivity reactions to iron products: 10-year experience in a Portuguese tertiary Centre. Eur Ann Allergy Clin Immunol 2023.
  10. Jara Vidal M, López García MC, Quílez Toboso RP. Kounis syndrome after intravenous iron administration. Med Clin (Barc) 2023.
Anemia Endocrine

Population research in females shows that higher ferritin levels are associated with an approximately 1.5-fold higher odds of developing gestational diabetes. Increased dietary intake of heme-iron, but not non-heme iron, is also associated with an increased risk for gestational diabetes. The effects of iron supplementation could not be determined from the evaluated research. However, in a sub-analysis of a large clinical trial in pregnant adults, daily supplementation with iron 100 mg from 14 weeks gestation until delivery did not affect the frequency or severity of glucose intolerance or gestational weight gain.

Intravenous (IV) iron may trigger hypophosphatemia in some patients. A meta-analysis of clinical studies in adults with iron deficiency anemia shows that IV ferric carboxymaltose is associated with a higher risk of hypophosphatemia when compared with other IV formulations (i.e. iron dextran, iron isomaltoside, iron sucrose, and ferumoxytol). Severe hypophosphatemia requiring IV phosphate has also occurred following IV ferric carboxymaltose.

Additionally, cases of osteomalacia related to hypophosphatemia subsequent to parenteral iron administration have been rarely reported.

  1. Khambalia AZ, Aimone A, Nagubandi P, et al. High maternal iron status, dietary iron intake and iron supplement use in pregnancy and risk of gestational diabetes mellitus: a prospective study and systematic review. Diabet Med. 2016;33(9):1211-21.
  2. Kinnunen TI, Luoto R, Helin A, Hemminki E. Supplemental iron intake and the risk of glucose intolerance in pregnancy: re-analysis of a randomised controlled trial in Finland. Matern Child Nutr. 2016;12(1):74-84.
  3. Ye S, Grill V, Luo J, Nguyen HH. Concurrent Denosumab and Parenteral Iron Therapy Precipitating Severe Hypocalcemia and Hypophosphatemia. JCEM Case Rep 2024;2(2):luae005.
  4. Bellos I, Frountzas M, Pergialiotis V. Comparative Risk of Hypophosphatemia Following the Administration of Intravenous Iron Formulations: A Network Meta-Analysis. Transfus Med Rev 2020;34(3):188-194.
  5. Jara Vidal M, Ruiz de Assín Valverde A, Aznar Rodríguez S. Severe hypophospathemia secondary to intravenous iron. Med Clin (Barc) 2023.
  6. Seng NW, Barco JB, Wong MH, et al. Hypophosphatemia related to intravenous iron therapy with ferric carboxymaltose: A case series. Transfus Med 2023.
  7. Kancherla K, Constantin H, Kanawati A, Graham E. Iron-induced Hypophosphatemic Osteomalacia-An Atypical Case of Bilateral Femoral Stress Fractures. J Am Acad Orthop Surg Glob Res Rev 2023;7(5):e22.
  8. Samões B, Silva B, Martins A, et al. Hypophosphatemic osteomalacia induced by intravenous iron therapy: a case report. Joint Bone Spine 2023;90(5):105586.
Back pain Other

Intravenously, sodium ferric gluconate complex (SFGC) caused drug intolerance reactions in 0.4% of hemodialysis patients including 2 patients with pruritus and one patient each with anaphylactoid reaction, hypotension, chills, back pain, dyspnea/chest pain, facial flushing, rash and cutaneous symptoms of porphyria.

  1. Michael, B., Coyne, D. W., Fishbane, S., Folkert, V., Lynn, R., Nissenson, A. R., Agarwal, R., Eschbach, J. W., Fadem, S. Z., Trout, J. R., Strobos, J., and Warnock, D. G. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compar
Burns Pulmonary/Respiratory

Orally, iron has been associated with rare reports of iron pill aspiration. This occurs when all or part of the pill is aspirated into the lungs. Once in the lungs, it can cause a chemical burn of the bronchial mucosa. Dozens of cases of iron pill aspiration have been reported in individuals ranging in age from 22 months to 92 years. Patients presented with cough, dyspnea, wheezing, and hemoptysis. The hemoptysis led to death in 2 patients due to hemorrhage. Long-term complication of fibrosis and bronchial stenosis was reported in a few of the cases. In one case, a 48-year-old female accidentally aspirated a ferrous sulfate tablet and presented to the emergency department with cough, blood-stained sputum, chest pain, dyspnea, and acute distress. Bronchoscopy was performed, parts of the pill were retrieved, and chemical burns and necrotic tissue were observed in the bronchus intermedius mucosa and throughout the middle and lower lobes. Debridement with bronchoalveolar lavage was performed. The patient was transferred to the intensive care unit, placed on mechanical ventilation for 2 days, treated with corticosteroids, and discharged on the fifth day of hospitalization. Four weeks post-discharge the patient had significantly improved but still had some reduction in lung capacity.

Cancer Oncologic

There is a debate regarding the association between high levels of iron stores and cancer. Data are conflicting and inconclusive. Epidemiological studies suggest that increased body iron stores may increase the risk of cancer or general mortality.

Occupational exposure to iron may be carcinogenic. Oral exposure to iron may also be carcinogenic. Pooled analyses of population studies suggest that increasing the intake of heme iron increases the risk of colorectal cancer. For example, increasing heme iron intake by 1 mg/day is associated with an 11% increase in risk.

  1. Ullen H, Augustsson K, Gustavsson C, Steineck G. Supplementary iron intake and risk of cancer: reversed causality? Cancer Lett 1997;114:215-6.
  2. Reunanen A, Takkunen H, Knekt P, et al. Body iron stores, dietary iron intake and coronary heart disease mortality. J Intern Med 1995;238:223-30.
  3. Lund EK, Wharf SG, Fairweather-Tait SJ, Johnson IT. Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am J Clin Nutr 1999;69:250-5.
  4. Rehman A, Collis CS, Yang M, et al. The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Comm 1998;246:293-8.
  5. Stevens, R. G. Iron and the risk of cancer. Med Oncol Tumor Pharmacother. 1990;7(2-3):177-181.
  6. Barbieri, P. G. [To-day exposure to occupational carcinogens and their effects. The experience of the rubber industry, iron metallurgy, asphalt work and aviculture]. Epidemiol.Prev 2009;33(4-5 Suppl 2):94-105.
  7. Bastide, N. M., Pierre, F. H., and Corpet, D. E. Heme iron from meat and risk of colorectal cancer: a meta-analysis and a review of the mechanisms involved. Cancer Prev Res (Phila) 2011;4(2):177-184.
  8. Qiao L, Feng Y. Intakes of heme iron and zinc and colorectal cancer incidence: a meta-analysis of prospective studies. Cancer Causes Control. 2013 Jun;24(6):1175-83.
Extravasation Dermatologic

Cutaneous hemosiderosis, or skin staining, has been reported following intravenous (IV) iron infusion in various case reports. Most of these cases are due to extravasation following iron infusion. In one case, extravasation has occurred following iron derisomaltose infusion in a 41-year-old female with chronic kidney disease. Rarely, diffuse cutaneous hermosiderosis has occurred. In one case, a 31-year-old female with excessive sweating developed cutaneous hemosiderosis in the armpits following an (IV) iron polymaltose infusion.

  1. Shi R, Marin JG, Beaulieu M. Skin staining following intravenous iron extravasation in a patient with chronic kidney disease: A case report. Can J Kidney Health Dis 2023;10:20543581231165705.
  2. Fernandez-Flores A, Fernandez-Parrado M, Alzoghby-Abi Chaker J, Angulo AG. Axillary cutaneous hemosiderosis in a patient with hyperhidrosis, after intravenous iron infusion. Am J Dermatopathol 2023;45(7):463-465.
DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.

Adverse-effects data: Natural Medicines, Therapeutic Research Center

Dosing

There is no single correct dose for everyone, because the right amount depends on your age, sex, whether you are pregnant, and how low your iron levels are. Treatment doses for anemia are usually higher than amounts found in a daily multivitamin.

Follow the dose on your product label or the dose your healthcare provider gives you. Taking iron with a source of vitamin C (such as orange juice) may improve absorption, while taking it with coffee, tea, dairy, or calcium supplements may reduce it.

Because both too little and too much iron can cause problems, ask a pharmacist or doctor to help you choose the right product and dose, and recheck your iron levels with a blood test as advised.

Pregnancy & Breastfeeding

Iron & Pregnancy

Likely Safe

When used orally and appropriately. Iron is safe during pregnancy and breast-feeding in patients with adequate iron stores when used in doses below the tolerable upper intake level (UL) of 45 mg daily of elemental iron.

  1. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002.
  2. Peña-Rosas JP, De-Regil LM, Gomez Malave H, Flores-Urrutia MC, Dowswell T. Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;(10):CD009997.
  3. Milman NT. Iron supplementation in pregnant Danish women revisited: Effects on prepartum and postpartum iron deficiency, anemia, serum erythropoietin; including iron status, erythropoietin and anthropometrics in newborns. A randomized, placebo-controlled
Likely Unsafe

When used orally in high doses. Tell patients who are not iron deficient to avoid exceeding the tolerable upper intake level (UL) of 45 mg daily of elemental iron. Higher doses frequently cause gastrointestinal side effects such as nausea and vomiting and might increase the risk of preterm labor. High hemoglobin concentrations at the time of delivery are associated with adverse pregnancy outcomes.

  1. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002.
  2. Brabin B, Gies S, Roberts SA, et al. Excess risk of preterm birth with periconceptional iron supplementation in a malaria endemic area: analysis of secondary data on birth outcomes in a double blind randomized controlled safety trial in Burkina Faso. Mala
  3. Tran T., Wax J. R., Philput C., Steinfeld J. D., Ingardia C. J. Intentional iron overdose in pregnancy--management and outcome. J Emerg Med 2000;18(2):225-228.

Iron & Breastfeeding

Likely Safe

When used orally and appropriately. Iron is safe during pregnancy and breast-feeding in patients with adequate iron stores when used in doses below the tolerable upper intake level (UL) of 45 mg daily of elemental iron.

  1. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002.
  2. Peña-Rosas JP, De-Regil LM, Gomez Malave H, Flores-Urrutia MC, Dowswell T. Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;(10):CD009997.
  3. Milman NT. Iron supplementation in pregnant Danish women revisited: Effects on prepartum and postpartum iron deficiency, anemia, serum erythropoietin; including iron status, erythropoietin and anthropometrics in newborns. A randomized, placebo-controlled
Likely Unsafe

When used orally in high doses. Tell patients who are not iron deficient to avoid exceeding the tolerable upper intake level (UL) of 45 mg daily of elemental iron. Higher doses frequently cause gastrointestinal side effects such as nausea and vomiting and might increase the risk of preterm labor. High hemoglobin concentrations at the time of delivery are associated with adverse pregnancy outcomes.

  1. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002.
  2. Brabin B, Gies S, Roberts SA, et al. Excess risk of preterm birth with periconceptional iron supplementation in a malaria endemic area: analysis of secondary data on birth outcomes in a double blind randomized controlled safety trial in Burkina Faso. Mala
  3. Tran T., Wax J. R., Philput C., Steinfeld J. D., Ingardia C. J. Intentional iron overdose in pregnancy--management and outcome. J Emerg Med 2000;18(2):225-228.
DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.

© 2026 Therapeutic Research Center

Pregnancy & lactation ratings: Natural Medicines, Therapeutic Research Center

References & further reading

The 72 references that drive our Iron monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  2. Bruner AB, Joffe A, Duggan AK, et al. Randomized study of cognitive effects of iron supplementation in non- anaemic iron-deficient adolescent girls. Lancet 1996;348:992-6.
  3. Ullen H, Augustsson K, Gustavsson C, Steineck G. Supplementary iron intake and risk of cancer: reversed causality? Cancer Lett 1997;114:215-6.
  4. Reunanen A, Takkunen H, Knekt P, et al. Body iron stores, dietary iron intake and coronary heart disease mortality. J Intern Med 1995;238:223-30. PubMed
  5. Lund EK, Wharf SG, Fairweather-Tait SJ, Johnson IT. Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am J Clin Nutr 1999;69:250-5.
  6. Rehman A, Collis CS, Yang M, et al. The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Comm 1998;246:293-8. PubMed
  7. Klipstein-Grobusch K, Grobbee DE, den Breeijen JH, et al. Dietary iron and risk of myocardial infarction in the Rotterdam Study. Am J Epidemiol 1999;149:421-8. PubMed
  8. Hansten PD, Horn JR. Drug Interactions Analysis and Management. Vancouver, WA: Applied Therapeutics Inc., 1997 and updates.
  9. Tatro DS, ed. Drug Interactions Facts. Facts and Comparisons Inc., St. Louis, MO. 1999.
  10. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002.
  11. Campbell N, Paddock V, Sundaram R. Alteration of methyldopa absorption, metabolism, and blood pressure control by ferrous sulfate and ferrous gluconate. Clin Pharmacol Ther 1988;43:381-6..
  12. Schumann K, Borch-Iohnsen B, Hentze MW, Marx JJ. Tolerable upper intakes for dietary iron set by the US Food and Nutrition Board (commentary). Am J Clin Nutr 2002;76:499-500. PubMed
  13. Tuomainen TP, Punnonen K, Nyyssonen K, Salonen JT. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 1998;97:1461-6.. PubMed
  14. Salonen JT, Nyyssonen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 1992;86:803-11.. PubMed
  15. Campbell NRC, Hasinoff B. Ferrous sulfate reduces levodopa bioavailability: Chelation as a possible mechanism. Clin Pharmacol Ther 1989;45:220-5.. PubMed
Keep reading

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Product directory

Supplement products with Iron

16,399 products in our database contain Iron. Open any to see its full ingredient list and every drug interaction we check.

100% Casein Protein Vanilla by GNC Pro Performance Powder 2 lb · 32 oz. · 909 g View ingredients & interactions 100% Egg Protein French Vanilla by Healthy 'N Fit Powder 2 Pound(s) · 908 Gram(s) View ingredients & interactions 100% Egg Protein Heavenly Chocolate by Healthy 'N Fit Powder 4 Pound(s) · 1815 Gram(s) View ingredients & interactions 100% Egg Protein Heavenly Chocolate by Healthy 'N Fit Powder 2 Pound(s) · 908 Gram(s) View ingredients & interactions 100% Egg Protein Heavenly Chocolate Flavor by Healthy 'N Fit Powder 12 Ounce(s) · 340 Gram(s) View ingredients & interactions 100% Egg Protein Unflavored by Healthy 'N Fit Powder 2 Pound(s) · 908 Gram(s) View ingredients & interactions 100% Egg Protein Vanilla Ice Cream by GNC Pro Performance Powder 25 Serving(s) · 30.39 oz. · 1.9 lb · 863 Gram(s) View ingredients & interactions 100% Egg Protein Vanilla Ice Cream by Healthy 'N Fit Powder 2 Pound(s) · 908 Gram(s) View ingredients & interactions 100% Egg Protein Vanilla Ice Cream by Healthy 'N Fit Powder 4 Pound(s) · 1815 Gram(s) View ingredients & interactions 100% Fermented Organic Greens Organic Chocolate by Natural Factors Whole Earth & Sea Powder 7.7 Ounce(s) · 219 Gram(s) View ingredients & interactions 100% Fermented Organic Greens Unflavored by Natural Factors Whole Earth & Sea Powder 6.9 Ounce(s) · 195 Gram(s) View ingredients & interactions 100% Greens+Whey Chocolate by BioChem Powder 10.7 oz. · 304 g View ingredients & interactions 100% Greens+Whey Chocolate by BioChem Powder 23.6 oz. · 670 g View ingredients & interactions 100% Hydrolyzed Protein Chocolate by GNC Pro Performance Powder 48 Oz(s) · 3 lb · 1364 Gram(s) View ingredients & interactions 100% Hydrolyzed Protein Vanilla by GNC Pro Performance Powder 48 Oz(s) · 3 lb · 1364 Gram(s) View ingredients & interactions 100% Isolate Chocolate Milkshake by IMSOALPHA Powder 907 Gram(s) · 32 Ounce(s) View ingredients & interactions 100% Isolate Protein Chocolate Peanut Butter by Evlution Nutrition Powder 1.6 Pound(s) · 726 Gram(s) View ingredients & interactions 100% Isolate Protein Double Rich Chocolate by Evlution Nutrition Powder 5 lb(s) · 2.268 Kilogram(s) View ingredients & interactions 100% Isolate Protein Unflavored by Evlution Nutrition Powder 1 Pound(s) · 454 Kilogram(s) View ingredients & interactions 100% Isolate Protein Vanilla Ice Cream by Evlution Nutrition Powder 5 Pound(s) · 2268 kg View ingredients & interactions 100% Isolate Vanilla Wafer by Bodybuilding.com Signature Powder 5 Pound(s) · 2.27 kg View ingredients & interactions 100% Mass Gainer Chocolate Fudge Brownie by MuscleTech Powder 5.15 Pound(s) · 2.33 kg View ingredients & interactions 100% Mass Gainer Vanilla Milkshake by Iovate Health Sciences (MuscleTech) Powder 5.15 Pound(s) · 2.33 KG(s) View ingredients & interactions 100% Micellar Casein Chocolate by MET-Rx Powder 2 lb · 32 oz. · 907 Gram(s) View ingredients & interactions
Pharmacist Counseling Corner

Iron: Common Questions

What is Iron used for, and does it work?
People use Iron for many reasons, but the evidence varies by use. According to the Natural Medicines database, there is at least some clinical evidence supporting Iron for Anemia of chronic disease, Iron deficiency anemia, Pregnancy-related iron deficiency and Breath-holding attacks. For most other uses it has been studied for, the evidence is currently insufficient to rate. See the graded list on this page, and always confirm with your pharmacist or doctor.
Does Iron interact with prescription medications?
Yes. We list 80 medications with a known interaction with Iron. Use the checker above to see how Iron interacts with a specific drug.
How are Iron interactions rated?
Each interaction is graded major, moderate, or minor based on how clinically significant it is and the strength of the evidence behind it. Major interactions are the most serious and are best avoided, or used only under close professional supervision.
Is it safe to take Iron with my medications?
It depends on the specific medication. Some combinations are fine, while others call for monitoring, timing changes, or should be avoided. Check your exact drug above and confirm with your pharmacist or doctor before starting, stopping, or changing anything.
Where does this Iron interaction information come from?
Our interaction data is built on the Natural Medicines database — an evidence-graded reference for vitamins, herbs, and supplements — and is reviewed by licensed HelloPharmacist pharmacists, who may add clinical context.
What is Iron used for?
Iron is mainly used to prevent and treat Iron deficiency and Iron-deficiency anemia, conditions where your body does not have enough Iron to make healthy red blood cells. It is also commonly recommended during pregnancy and for people with ongoing blood loss.
Should I take Iron if I feel tired?
Iron only helps fatigue if your tiredness is actually caused by low Iron. Taking Iron when you are not deficient will not boost your energy and can cause harm, so it is best to get a blood test before starting Iron.
Why does Iron upset my stomach?
Iron commonly causes nausea, constipation, or stomach cramps. Taking it with food, using a lower dose, or trying a different form may help, and dark or black stools while on Iron are normal and harmless.
Can I take Iron during pregnancy?
Iron is often part of prenatal care because pregnancy increases Iron needs, but the right dose should be guided by your doctor or midwife. Avoid taking high-dose Iron on your own without medical advice.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Have a question about Iron?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist